Brief: Orbimed Advisors Reports 11.2% Stake In Gracell Biotechnologies
31/03/2023 22:56
March 31 (Reuters) - Gracell Biotechnologies Inc
GRCL.O :
* ORBIMED ADVISORS LLC REPORTS 11.2% STAKE IN GRACELL
BIOTECHNOLOGIES INC AS OF MARCH 29, 2023
Source text for Eikon: ID:
Further company coverage: GRCL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gracell Biotechnologies
See all newsBrief: Gracell Biotechnologies Announces Shareholders’ Approval Of Merger Agreement
Brief: Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple Myeloma
Newscasts - UK Day Ahead: European shares start last week of 2023 on strong footing
Live Markets: European futures rise after holiday break
Press Digest: British Business - Dec 27